SCHEMBL19994264

SCHEMBL19994264

Cc1c(CN2CCNC2=O)sc2c1c(=O)n(C1CC(F)(F)C1)c(=O)n2CCC(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 12/20 0.53
ADORA2A P29274 7/20 0.53
ADORA1 P30542 7/20 0.53
ADORA3 P0DMS8 4/20 0.51
ACACA Q13085 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19995144 0.93 ADORA2B (0.51) ADORA2BADORA2AADORA1ADORA3
SCHEMBL20014420 0.92 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3ACACA
SCHEMBL20015037 0.91 ADORA2B (0.55) ADORA2BADORA2AADORA1ADORA3
SCHEMBL19994330 0.91 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3
SCHEMBL20015114 0.89 ADORA2B (0.53) ADORA2BADORA2AADORA1ADORA3
SCHEMBL20014237 0.89 ADORA2B (0.53) ADORA2BADORA2AADORA1ADORA3
SCHEMBL20014251 0.89 ADORA2B (0.52) ADORA2BADORA2AADORA1ADORA3
SCHEMBL20015107 0.89 ADORA2B (0.52) ADORA2BADORA2AADORA1ADORA3
SCHEMBL19993877 0.89 ADORA2B (0.52) ADORA2BADORA2AADORA1ADORA3
SCHEMBL19995149 0.88 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3ACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515919-A1 N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2019-07-31 EP disclosed
WO-2018054846-A1 N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-03-29 WO disclosed
WO-2018054846-A1 N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-03-29 WO disclosed